Vicki L Wheelock, MD

Professor

  • 1230 Citations
  • 24 h-Index
20032018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Vicki L Wheelock is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Huntington Disease Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences
Cognition Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Cytosine Medicine & Life Sciences
Mesenchymal Stromal Cells Medicine & Life Sciences
coenzyme Q10 Medicine & Life Sciences
Guanine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2018

  • 1230 Citations
  • 24 h-Index
  • 40 Article
1 Citation (Scopus)

High and low levels of an NTRK2-driven genetic profile affect motor- and cognition-associated frontal gray matter in prodromal Huntington’s disease

PREDICT-HD Investigators and Coordinators of the Huntington, Jul 1 2018, In : Brain Sciences. 8, 7, 116.

Research output: Contribution to journalArticle

Huntington Disease
Cognition
trkB Receptor
Trail Making Test
Brain-Derived Neurotrophic Factor

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

McGarry, A., McDermott, M., Kieburtz, K., DeBlieck, E. A., Beal, F., Marder, K., Ross, C., Shoulson, I., Gilbert, P., Mallonee, W. M., Guttman, M., Wojcieszek, J., Kumar, R., LeDoux, M. S., Jenkins, M., Rosas, H. D., Nance, M., Biglan, K., Como, P., Dubinsky, R. M. & 40 others, Shannon, K. M., O'Suilleabhain, P., Chou, K., Walker, F., Martin, W., Wheelock, V. L., McCusker, E., Jankovic, J., Singer, C., Sanchez-Ramos, J., Scott, B., Suchowersky, O., Factor, S. A., Higgins, D. S., Molho, E., Revilla, F., Caviness, J. N., Friedman, J. H., Perlmutter, J. S., Feigin, A., Anderson, K., Rodriguez, R., McFarland, N. R., Margolis, R. L., Farbman, E. S., Raymond, L. A., Suski, V., Kostyk, S., Colcher, A., Seeberger, L., Epping, E., Esmail, S., Diaz, N., Alan Fung, W. L., Diamond, A., Frank, S., Hanna, P., Hermanowicz, N., Dure, L. S. & Cudkowicz, M., Jan 10 2017, In : Neurology. 88, 2, p. 152-159 8 p.

Research output: Contribution to journalArticle

coenzyme Q10
Huntington Disease
Placebos
Medical Futility
Canada
6 Citations (Scopus)
Psychotic Disorders
Antipsychotic Agents
Parkinson Disease
Retrospective Studies
Drug-Related Side Effects and Adverse Reactions
11 Citations (Scopus)

Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human huntington’s disease fibroblasts

Fink, K., Deng, P., Gutierrez, J., Anderson, J. S., Torrest, A., Komarla, A., Kalomoiris, S., Cary, W., Anderson, J., Gruenloh, W., Duffy, A., Tempkin, T., Annett, G., Wheelock, V. L., Segal, D. & Nolta, J., 2016, In : Cell Transplantation. 25, 4, p. 677-686 10 p.

Research output: Contribution to journalArticle

Huntington Disease
Transcription
Fibroblasts
Nucleotides
Polymorphism
21 Citations (Scopus)

Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS) implications for clinical trials

The Huntington Study Group PHAROS Investigators, Jan 1 2016, In : JAMA neurology. 73, 1, p. 102-110 9 p.

Research output: Contribution to journalArticle

Open Access
Cytosine
Guanine
Adenine
Huntington Disease
Observational Studies